Nebenwirkungen · Rhapsido
Rhapsido 25 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 6
HOS-152633 · Präparat HOS-100797
Adverse reactions are listed according to MedDRA system organ class. Within each system organ class, the adverse reactions are ranked by frequency, with the most frequent reactions first. In addition, the corresponding frequency category for each adverse reaction is defined as: very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1 000 to <1/100); rare (≥1/10 000 to <1/1 000); very rare (<1/10 000); not known (cannot be estimated from available data).
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-05-05T16:52:08Z · SHA-256 9935c4a67377101dad55c6c30e4a96e3b62b4ad99c3b025c6771b6bbf84fb92f · Passage a3c41c1ad4e5ba90607b29a77c46d04ec4b488c69424c2981d68ab8ec66937ac · Zeichen 214–676 im Abschnitt